These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20573594)

  • 21. Nephrotoxicity caused by brown spider venom phospholipase-D (dermonecrotic toxin) depends on catalytic activity.
    Kusma J; Chaim OM; Wille AC; Ferrer VP; Sade YB; Donatti L; Gremski W; Mangili OC; Veiga SS
    Biochimie; 2008; 90(11-12):1722-36. PubMed ID: 18760322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological and biochemical evidence of blood vessel damage and fibrinogenolysis triggered by brown spider venom.
    Zanetti VC; da Silveira RB; Dreyfuss JL; Haoach J; Mangili OC; Veiga SS; Gremski W
    Blood Coagul Fibrinolysis; 2002 Mar; 13(2):135-48. PubMed ID: 11914656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the toxic potential of venom from Loxosceles adelaida, a Brazilian brown spider from karstic areas.
    Pretel F; Gonçalves-de-Andrade RM; Magnoli FC; da Silva ME; Ferreira JM; van den Berg CW; Tambourgi DV
    Toxicon; 2005 Mar; 45(4):449-58. PubMed ID: 15733566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway.
    Tambourgi DV; Magnoli FC; Von Eickstedt VR; Benedetti ZC; Petricevich VL; da Silva WD
    J Immunol; 1995 Nov; 155(9):4459-66. PubMed ID: 7594608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
    de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
    Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning, expression and characterization of a phospholipase D from Loxosceles gaucho venom gland.
    Magalhães GS; Caporrino MC; Della-Casa MS; Kimura LF; Prezotto-Neto JP; Fukuda DA; Portes-Junior JA; Neves-Ferreira AG; Santoro ML; Barbaro KC
    Biochimie; 2013 Sep; 95(9):1773-83. PubMed ID: 23770445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification, cloning and functional characterization of a novel dermonecrotic toxin (phospholipase D) from brown spider (Loxosceles intermedia) venom.
    Appel MH; da Silveira RB; Chaim OM; Paludo KS; Silva DT; Chaves DM; da Silva PH; Mangili OC; Senff-Ribeiro A; Gremski W; Nader HB; Veiga SS
    Biochim Biophys Acta; 2008 Feb; 1780(2):167-78. PubMed ID: 18082635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the venom and the dermonecrotic toxin LiRecDT1 of Loxosceles intermedia in the rat liver.
    de Oliveira Christoff A; de Oliveira A; Chaim OM; Lugarini D; Bastos Pereira AL; Paludo KS; Queiroz Telles JE; Bracht A; Veiga SS; Acco A
    Toxicon; 2008 Nov; 52(6):695-704. PubMed ID: 18765244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and neutralization of biological activities in the venoms of Loxosceles spiders.
    Barbaro KC; Ferreira ML; Cardoso DF; Eickstedt VR; Mota I
    Braz J Med Biol Res; 1996 Nov; 29(11):1491-7. PubMed ID: 9196551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes.
    Felicori L; Fernandes PB; Giusta MS; Duarte CG; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Vaccine; 2009 Jun; 27(31):4201-8. PubMed ID: 19389441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipase-D activity and inflammatory response induced by brown spider dermonecrotic toxin: endothelial cell membrane phospholipids as targets for toxicity.
    Chaim OM; da Silveira RB; Trevisan-Silva D; Ferrer VP; Sade YB; Bóia-Ferreira M; Gremski LH; Gremski W; Senff-Ribeiro A; Takahashi HK; Toledo MS; Nader HB; Veiga SS
    Biochim Biophys Acta; 2011 Feb; 1811(2):84-96. PubMed ID: 21094694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
    Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental evidence for a direct cytotoxicity of Loxosceles intermedia (brown spider) venom in renal tissue.
    Luciano MN; da Silva PH; Chaim OM; dos Santos VL; Franco CR; Soares MF; Zanata SM; Mangili OC; Gremski W; Veiga SS
    J Histochem Cytochem; 2004 Apr; 52(4):455-67. PubMed ID: 15033997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysis.
    Tambourgi DV; Magnoli FC; van den Berg CW; Morgan BP; de Araujo PS; Alves EW; Da Silva WD
    Biochem Biophys Res Commun; 1998 Oct; 251(1):366-73. PubMed ID: 9790962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular matrix molecules as targets for brown spider venom toxins.
    Veiga SS; Zanetti VC; Braz A; Mangili OC; Gremski W
    Braz J Med Biol Res; 2001 Jul; 34(7):843-50. PubMed ID: 11449301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brown spider (Loxosceles genus) venom toxins: Evaluation of biological conservation by immune cross-reactivity.
    Buch DR; Souza FN; Meissner GO; Morgon AM; Gremski LH; Ferrer VP; Trevisan-Silva D; Matsubara FH; Boia-Ferreira M; Sade YB; Chaves-Moreira D; Gremski W; Veiga SS; Chaim OM; Senff-Ribeiro A
    Toxicon; 2015 Dec; 108():154-66. PubMed ID: 26474948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
    Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
    Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Loxtox protein family in Loxosceles intermedia (Mello-Leitão) venom.
    Kalapothakis E; Chatzaki M; Gonçalves-Dornelas H; de Castro CS; Silvestre FG; Laborne FV; de Moura JF; Veiga SS; Chávez-Olórtegui C; Granier C; Barbaro KC
    Toxicon; 2007 Dec; 50(7):938-46. PubMed ID: 17825864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effect of the Phoneutria nigriventer spider venom on cell viability, paracellular barrier function and transcellular transport in cultured cell lines.
    de Paula Le Sueur L; Collares-Buzato CB; Kalapothakis E; da Cruz-Höfling MA
    Toxicon; 2005 Aug; 46(2):130-41. PubMed ID: 15949833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands.
    Tambourgi DV; de F Fernandes Pedrosa M; van den Berg CW; Gonçalves-de-Andrade RM; Ferracini M; Paixão-Cavalcante D; Morgan BP; Rushmere NK
    Mol Immunol; 2004 Jul; 41(8):831-40. PubMed ID: 15234562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.